Materialise NV, recognized by its ticker symbol MTLS, is a leading pioneer and global provider in the thriving sector of 3D printing technology. This Belgium-based company was established in 1990 and has since grown to become one of the pioneering players in the additive manufacturing industry, a fact that underscores its long-standing experience and deep-rooted expertise. Materialise provides innovative software solutions, sophisticated design, and advanced manufacturing services to a broad array of industries such as healthcare, automotive, aerospace, and consumer goods, amongst others.
Materialise’s operations are significant in the 3D printing ecosystem, comprising three key segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment develops and delivers valuable 3D printing software and related solutions designed to facilitate 3D design, engineering, 3D printing, and additive manufacturing. It grants businesses and researchers the tools needed to design innovative products more effectively and efficiently.
The Materialise Medical segment focuses on providing medical 3D printing services and software solutions, highlighting the critical role of 3D printing technology in the personalized health care sector. Its offerings include surgical planning, medical implants, and other medical devices with the vital feature of customization according to individual patient's unique body structure.
The Materialise Manufacturing segment, on the other hand, offers 3D printed prototypes, tools, and serialized production parts to a multitude of industries. Their engineers collaborate with designers and production teams to create cutting-edge solutions that combine the potential of cutting-edge technologies and materials.
Materialise's commitment to sustainable practices alongside technological advancement is also noteworthy. It understands the need to develop responsible business processes and strives to reduce the carbon footprint and waste generation associated with traditional manufacturing.
Evidently, Materialise NV (MTLS) is not just an additive manufacturing company. It’s a place where ideas are materialized, taking shape and form through innovative technology. As the company slogan suggests, they are firmly committed to creating a better and healthier world by harnessing the power of innovation that 'makes the world a better and healthier place.'
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
Materialise (NASDAQ:MTLS) stock reached a new 52-week high of $8.48, trading up 5.8%. Despite this, analysts maintain a "Hold" rating with an average target price of $10.00. The company reported quarterly EPS of $0.07 on $78.9 million in revenue, and institutional investors now own 19.3% of the stock.
Materialise (NASDAQ:MTLS) shares have risen above their 50-day moving average, trading at $8.01 with a 50-day average of $7.00. Analysts currently hold a "Hold" rating on the stock with an average price target of $10.00. The company reported quarterly revenue of $78.9 million and earnings of $0.07 per share, with institutional investors owning approximately 19.3% of the stock.
_07_03_2026_03_50_21_133108.jpg)
Materialise NV (NASDAQ: MTLS) recently repurchased 73,335 shares for 453,314 EUR between August 31 and September 4, 2026. This adds to their ongoing buyback program, which has accumulated 1,279,715 shares, representing 2.2% of total outstanding shares, at a total cost of 6,446,397 EUR (7,532,366 USD). The company operates under a 30 million EUR discretionary buyback mandate and will provide weekly updates on its activities.
Materialise (MTLS) is projected to announce its Q2 2026 earnings before market open on Thursday, August 27th. Analysts anticipate earnings of $0.0457 per share and revenue of $78.2310 million. The company's stock opened at $6.57, with a market capitalization of $388.09 million, and analysts currently hold a consensus "Hold" rating with a $10.00 price target.